Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
Getinge to divest biosurgery business to HJ Capital 1
October 19, 2018

Atrium Medical Corporation, a subsidiary of Swedish Getinge, divests its biosurgery business to HJ Capital 1, the parent company of SeCQure Surgical Corporation, a global medical device company. Sales in 2017 relating to the biosurgery business amounted to approximately SEK 128m. The biosurgery business has been a relatively small segment within Getinge’s overall portfolio. The divestment is a strategic decision in order to focus on core therapeutic solutions.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: